also I agree, they’ve set themselves high targets and will be punished in the short term if they don’t meet them. But I don’t think the market ever actually believed they would reach it either so the re rating upwards is yet to really occur.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
